IDEXX Laboratories Inc. (IDXX)

269.82
1.50 0.55
NASDAQ : Health Technology
Prev Close 271.31
Open 272.33
Day Low/High 268.53 / 272.67
52 Wk Low/High 176.11 / 278.61
Volume 301.44K
Avg Volume 427.10K
Exchange NASDAQ
Shares Outstanding 86.01M
Market Cap 23.65B
EPS 4.30
P/E Ratio 62.22
Div & Yield N.A. (N.A)

Latest News

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer takes a look at Wheaton Precious Metals, Cirrus Logic, PetMed Express, Knight Transportation, Chart Industries and more.

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine, May 1, 2019 /PRNewswire/ --  Reports revenue growth of 7% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 9% reported and 12% organic Delivers EPS of $1.

IDEXX CEO Establishes Wild Cat Conservation Foundation

IDEXX CEO Establishes Wild Cat Conservation Foundation

WESTBROOK, Maine, April 23, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that its Chairman and Chief Executive Officer, Jonathan Ayers, and his wife, Helaine, have...

The New #38 Most Shorted Nasdaq 100 Component: Idexx Laboratories

The New #38 Most Shorted Nasdaq 100 Component: Idexx Laboratories

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IDEXX Laboratories To Release 2019 First Quarter Financial Results

IDEXX Laboratories To Release 2019 First Quarter Financial Results

WESTBROOK, Maine, April 2, 2019 /PRNewswire/ --  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 first quarter financial...

IDEXX Names Sharon Underberg General Counsel

IDEXX Names Sharon Underberg General Counsel

WESTBROOK, Maine, March 4, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Sharon Underberg has been appointed the...

IDEXX Laboratories To Present At Two Upcoming Institutional Investor Conferences

IDEXX Laboratories To Present At Two Upcoming Institutional Investor Conferences

WESTBROOK, Maine, Feb. 11, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc.

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Jim Cramer says Wednesday brought multiple positive earnings surprises that prompt us to ask how is it possible that these moves can occur without warning?

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Jim Cramer weighs in on Canada Goose, Wix.com, Yext, Idexx Laboratories, Yeti, Clean Harbors, Nio and more.

IDEXX Laboratories Announces Fourth Quarter And Full Year 2018 Results

IDEXX Laboratories Announces Fourth Quarter And Full Year 2018 Results

WESTBROOK, Maine, Feb. 1, 2019 /PRNewswire/ -- Achieves revenue growth in Q4 of 9% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic Reports 15% year-over-year increase in...

Watch Out for the Wave: Cramer's 'Mad Money' Recap (Tuesday 1/29/19)

Watch Out for the Wave: Cramer's 'Mad Money' Recap (Tuesday 1/29/19)

Jim Cramer says that if expectations are too high, even a great quarter cannot save you from the wave of selling.

Carvana, Bank OZK, Idexx Labs: 'Mad Money' Lightning Round

Carvana, Bank OZK, Idexx Labs: 'Mad Money' Lightning Round

Jim Cramer takes a look at Carvana, Bank OZK, Idexx Labs, Patterson-UTI Energy, 3D Systems, AbbVie and more.

IDEXX Expands SediVue Dx® Analyzer Medical Utility And Imaging Capabilities With Latest Software Update

IDEXX Expands SediVue Dx® Analyzer Medical Utility And Imaging Capabilities With Latest Software Update

World's largest veterinary image library powers Neural Network 4.0 advancements

IDEXX Introduces Exclusive Point-of-Care Progesterone Test To Its Catalyst Platform

IDEXX Introduces Exclusive Point-of-Care Progesterone Test To Its Catalyst Platform

New in-house diagnostic enables real-time and accurate prediction of timing for canine breeding

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Starbucks, Square, Alibaba: 'Mad Money' Lightning Round

Jim Cramer weighs in on Starbucks, Square, Alibaba, ArcelorMittal, Dynavax Technologies, Aimmune Therapeutics, Clearway Energy and more.

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

Breaking Down Citigroup Earnings: Cramer's 'Mad Money' Recap (Monday 1/14/19)

We may be so worried about the state of the global economy that we're missing some great opportunities, Jim Cramer says.

IDEXX Laboratories To Release 2018 Fourth Quarter And Full-Year Financial Results

IDEXX Laboratories To Release 2018 Fourth Quarter And Full-Year Financial Results

WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ --  IDEXX Laboratories, Inc.

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

Conflicting data about the economy should give the Federal Reserve pause.

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Jim Cramer's big takeaways? From cars and homebuilders to chips, he sees pockets of dramatic slowing.

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

TheStreet Quant Rating: B+ (Buy)